106
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis

ORCID Icon, , , , , ORCID Icon, , & show all
Pages 269-276 | Received 12 Nov 2020, Accepted 26 Jan 2021, Published online: 04 Feb 2021

References

  • Billingham ME. Histopathology of graft coronary disease. J Heart Lung transplant. 1992;11(3):S38–44.
  • Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multi institutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung transplant. 1998 Aug 1;17(8):744–753.
  • Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: thirty-first official adult heart transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant. 2014 Oct 1;33(10):996–1008.
  • Ramzy D, Rao V, Brahm J, et al. Cardiac allograft vasculopathy: a review. Can J Surg. 2005 Aug;48(4):319.
  • Kobashigawa JA, Moriguchi JD, Laks H, et al. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant. 2005 Nov 1;24(11):1736–1740.
  • Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation. 2004 Oct 26;110(17):2694–2700.
  • Schroeder JS, Gao SZ. Calcium blockers and atherosclerosis: lessons from the Stanford transplant coronary artery disease/diltiazem trial. Can J Cardiol. 1995 Sep;11(8):710.
  • Lee MS, Yang T, Fearon WF, et al. Long-term outcomes after percutaneous coronary intervention of the left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation. Am J Cardiol. 2010 Oct 15;106(8):1086–1089.
  • Aranda JM Jr, Pauly DF, Kerensky RA, et al. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy: one center’s experience. J Heart Lung Transplant. 2002 Aug 1;21(8):860–866.
  • Agarwal S, Parashar A, Kapadia SR, et al. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention. JACC Heart Fail. 2014 Jun 1;2(3):281–288.
  • Arora S, Andreassen A, Simonsen S, et al. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy. Transplantation. 2007 Jul 27;84(2):149–154.
  • Boyle JM, Moualla S, Arrigain S, et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Diseases. 2006 Nov 1;48(5):787–796.
  • Crawford TC, Magruder JT, Grimm JC, et al. A comprehensive risk score to predict prolonged hospital length of stay after heart transplantation. Ann Thorac Surg. 2018 Jan 1;105(1):83–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.